SOLUTEX GC – Trademark Portfolio
Entity Type: 16
SOLUTEX GC holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 4 trademarks are registered and 3 are pending. Notable registered marks include SOLUTEX, LIPINOVA, MAGOMEGA, and SLTEX WARRANTY SEAL. The owner is based in Alcobendas.
Avenida de la Transición Española,
24 Planta 3
Alcobendas E-28108 , ES
Showing of trademarks Trademarks
Trademark Classifications
SOLUTEX GC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does SOLUTEX GC have?
SOLUTEX GC has 10 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 pending, 2 abandoned.
What trademark classes does SOLUTEX GC file in?
SOLUTEX GC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 31 (Natural Agricultural Products), Class 40 (Treatment & Processing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SOLUTEX GC's most well-known trademarks?
SOLUTEX GC's registered trademark portfolio includes well-known marks such as SOLUTEX, LIPINOVA, MAGOMEGA, and SLTEX WARRANTY SEAL. These are among 4 currently registered trademarks in the portfolio.
What is SOLUTEX GC's trademark registration success rate?
SOLUTEX GC has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 3 applications are pending review.